By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – As part of a plan to inject $50 million into Alzheimer's disease studies announced last month, the National Institutes of Health will fund new research by small businesses that seek to discover disease and drug-related biomarkers.
Registering provides access to this and other free content.
Already have an account?Login Now.
David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.
In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.
Adam Rutherford discusses genetic genealogy at the Guardian.
Portions of the US 21st Century Cures Act are raising some safety concerns.